FR2482861A1 - Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal - Google Patents
Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal Download PDFInfo
- Publication number
- FR2482861A1 FR2482861A1 FR8110140A FR8110140A FR2482861A1 FR 2482861 A1 FR2482861 A1 FR 2482861A1 FR 8110140 A FR8110140 A FR 8110140A FR 8110140 A FR8110140 A FR 8110140A FR 2482861 A1 FR2482861 A1 FR 2482861A1
- Authority
- FR
- France
- Prior art keywords
- asn
- peptide
- lys
- arg
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6804080A JPS56163456A (en) | 1980-05-21 | 1980-05-21 | Preparation of antigen |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2482861A1 true FR2482861A1 (fr) | 1981-11-27 |
FR2482861B1 FR2482861B1 (US20030199744A1-20031023-C00003.png) | 1983-09-09 |
Family
ID=13362282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8110140A Granted FR2482861A1 (fr) | 1980-05-21 | 1981-05-21 | Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal |
Country Status (8)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4572800A (en) * | 1982-09-30 | 1986-02-25 | Otsuka Pharmaceutical Co., Ltd. | Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
CA1256795A (en) * | 1983-12-28 | 1989-07-04 | Dennis A. Carson | Anti-idiotype antibodies induced by synthetic polypeptides |
US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
US4654419A (en) * | 1984-08-08 | 1987-03-31 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
US5116725A (en) * | 1984-08-08 | 1992-05-26 | Scripps Clinic And Research Foundation | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
JPS62500452A (ja) * | 1984-09-19 | 1987-02-26 | ザ リ−ジエンツ オブ ザ ユニバ−シテイ オブ カリフオルニア | ヒト細胞形質転換に関連するレトロウイルスポリペプチド |
US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
JPH0792458B2 (ja) * | 1986-03-14 | 1995-10-09 | 郁男 山科 | 糖鎖特異抗体アツセイプレ−ト及びその製造方法 |
US5202270A (en) * | 1986-05-15 | 1993-04-13 | Abbott Laboratories | Cocaine and cocaine metabolites assay tracers, immunogens and antibodies |
US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
EA201790377A1 (ru) | 2014-09-16 | 2017-08-31 | Регенерон Фармасьютикалз, Инк. | Антитела к глюкагону и их применения |
SG11201901355SA (en) | 2016-08-30 | 2019-03-28 | Regeneron Pharma | Methods of treating severe insulin resistance by interfering with glucagon receptor signaling |
EP3529278A1 (en) | 2016-10-20 | 2019-08-28 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
EP3672620A1 (en) | 2017-08-22 | 2020-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of treating urea cycle disorders by interfering with glucagon receptor signaling |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2380296A1 (fr) * | 1977-02-10 | 1978-09-08 | Otsuka Pharma Co Ltd | Procede pour preparer un antigene et un anticorps |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4206199A (en) * | 1977-07-22 | 1980-06-03 | Takeda Chemical Industries, Ltd. | Novel glucagon fragment and its derivatives |
-
1980
- 1980-05-21 JP JP6804080A patent/JPS56163456A/ja active Granted
-
1981
- 1981-05-20 DK DK222081A patent/DK159163C/da not_active IP Right Cessation
- 1981-05-20 SE SE8103198A patent/SE454301B/sv not_active IP Right Cessation
- 1981-05-21 DE DE3120312A patent/DE3120312C2/de not_active Expired
- 1981-05-21 FR FR8110140A patent/FR2482861A1/fr active Granted
- 1981-05-21 BE BE0/204863A patent/BE888906A/fr not_active IP Right Cessation
- 1981-05-21 GB GB8115648A patent/GB2079289B/en not_active Expired
- 1981-05-21 US US06/265,926 patent/US4407965A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2380296A1 (fr) * | 1977-02-10 | 1978-09-08 | Otsuka Pharma Co Ltd | Procede pour preparer un antigene et un anticorps |
Non-Patent Citations (2)
Title |
---|
CA1978 * |
CA1980 * |
Also Published As
Publication number | Publication date |
---|---|
US4407965A (en) | 1983-10-04 |
JPS56163456A (en) | 1981-12-16 |
GB2079289A (en) | 1982-01-20 |
DE3120312C2 (de) | 1985-08-29 |
JPS6223822B2 (US20030199744A1-20031023-C00003.png) | 1987-05-25 |
DK159163C (da) | 1991-02-11 |
DE3120312A1 (de) | 1982-03-04 |
GB2079289B (en) | 1983-10-26 |
SE454301B (sv) | 1988-04-18 |
SE8103198L (sv) | 1981-11-22 |
DK159163B (da) | 1990-09-10 |
FR2482861B1 (US20030199744A1-20031023-C00003.png) | 1983-09-09 |
BE888906A (fr) | 1981-11-23 |
DK222081A (da) | 1981-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4423034A (en) | Process for the preparation of antibodies | |
EP0093652B1 (fr) | Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant | |
FR2482861A1 (fr) | Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal | |
FR2503145A1 (fr) | Peptides apparentes aux interferons humains, anticorps obtenus a partir de ces peptides et adsorbants obtenus a partir de ces anticorps | |
JPH0210159A (ja) | 螢光偏光免疫検定法原理によるタンパク質の測定方法およびハイブリッドクローン | |
EP0232693A2 (fr) | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
FR2521553A1 (fr) | Glycine 8-calcitonine | |
GB2062644A (en) | Glucagon fragment and utility hereof | |
EP0569309B2 (fr) | Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier | |
WO2001013114A1 (fr) | Composes synthetiques portant deux epitopes pour immunodosages | |
JP3055063B2 (ja) | 抗体精製法に有用なヒト絨毛性性腺刺激ホルモン(hCG)ペプチド | |
JP4120846B2 (ja) | 活性化ペプチド類および接合体 | |
FR2497198A1 (fr) | Peptide pour le dosage de l'hormone parathyroide humaine | |
FR2756827A1 (fr) | Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i | |
Nachtmann et al. | Oxytocin | |
JP4258271B2 (ja) | ポリアミノ酸担体 | |
EP0785432B1 (fr) | Procédé pour l'identification ou le dosage immunologique d'antigènes polypeptidiques | |
FR2737209A1 (fr) | Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c | |
FR2470113A1 (fr) | Derives de c-peptides de proinsuline tyrosylee et leur utilisation pour la determination des niveaux de c-peptide de proinsuline dans le serum humain | |
FR2521554A1 (fr) | Des-asparagine-3-calcitonine | |
EP0494825A1 (fr) | Peptides synthétiques dérivant de l'antigène HBc du virus de l'hépatite B | |
JPS6341425B2 (US20030199744A1-20031023-C00003.png) | ||
FR2601020A1 (fr) | Sorbine purifiee, nouveaux peptides ayant des sequences peptidiques en commun avec la sorbine et compositions pharmaceutiques les contenant | |
FR2458539A1 (fr) | Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique | |
JPH0453880B2 (US20030199744A1-20031023-C00003.png) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |